Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hyphens Pharma InternationalSGX:1J5 -2.70%82 PB Ratio is 1.68 as of Sep. 07, 2026, which is 9% above its 10-year median of 1.54. GuruFocus rates SGX:1J5 with a GF Score™ of 82/100 and a GF Value™ of S$0.31 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 115 Medical Distribution companies, Hyphens Pharma International ranks worse than 64.35% on this metric.
Hyphens Pharma International Ltd stock PB Ratio (=1.68) is close to 3-year high of 1.68.
The historical rank and industry rank for Hyphens Pharma International's PB Ratio or its related term are showing as below:
SGX:1J5'
s PB Ratio Range Over the Past 10 Years
Min: 1.17 Med: 1.54 Max: 4.37
Current: 1.68
During the past 11 years, Hyphens Pharma International's highest PB Ratio was 4.37. The lowest was 1.17. And the median was 1.54.
SGX:1J5's PB Ratio is ranked worse than 64.35% of 115
companies
in the Medical Distribution industry
Industry Median: 1.07
vs SGX:1J5: 1.68
During the past 12 months, Hyphens Pharma International's average Book Value Per Share Growth Rate was 1.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 17.00% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Hyphens Pharma International was 37.00% per year. The lowest was 0.40% per year. And the median was 12.85% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hyphens Pharma International PB Ratio Related Terms
Hyphens Pharma International PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Hyphens Pharma International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hyphens Pharma International PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hyphens Pharma International's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hyphens Pharma International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hyphens Pharma International (SGX:1J5) has a PB Ratio of 1.68 as of Sep. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hyphens Pharma International and its competitors. This is near median its historical median of 1.54. Over the past decade, Hyphens Pharma International's PB Ratio has ranged from 1.17 to 4.37. According to the industry distribution chart, Hyphens Pharma International ranks #74 out of 115 companies in the Medical Distribution industry, placing it in the top 64.3%.
Is Hyphens Pharma International's PB Ratio too high?
Hyphens Pharma International's current PB Ratio of 1.68 is near median its 10-year median of 1.54. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 4.37. The Medical Distribution industry median PB Ratio is 1.07. Hyphens Pharma International's value of 1.68 is 57% above this industry median. Based on the distribution chart, Hyphens Pharma International ranks #74 out of 115 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Hyphens Pharma International has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hyphens Pharma International's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Hyphens Pharma International ranks #74 out of 115 companies for PB Ratio. This places Hyphens Pharma International in the lower half of its industry. The industry median PB Ratio is 1.07. Hyphens Pharma International's value of 1.68 is 57% above this benchmark. Historically, Hyphens Pharma International's own PB Ratio has ranged from 1.17 to 4.37 over the past decade. While the company's 10-year median is 1.54 vs. the industry median of 1.07, Hyphens Pharma International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.07, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hyphens Pharma International's current PB Ratio of 1.68 is 57% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hyphens Pharma International and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hyphens Pharma International's current PB Ratio is 1.68, which is near median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hyphens Pharma International stock overvalued right now?
Based on GuruFocus' analysis, Hyphens Pharma International (SGX:1J5) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.31, compared to a current price of S$0.36 — trading 16.1% above its estimated fair value. The current PB Ratio is 1.68, which is near median its 10-year median of 1.54 and 57% above the Medical Distribution industry median of 1.07. Hyphens Pharma International's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hyphens Pharma International (SGX:1J5), the current PB Ratio is 1.68 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hyphens Pharma International (SGX:1J5) Overvalued in 2026?
Based on GuruFocus' analysis, Hyphens Pharma International stock appears to be overvalued.
The current stock price of S$0.36 is trading 16.1% above its estimated GF Value™ of S$0.31.
GuruFocus considers Hyphens Pharma International to be Modestly Overvalued.
Key valuation signals for SGX:1J5:
PB Ratio: 1.68 (near median its 10-year median of 1.54)
GF Value™: S$0.31 vs. price of S$0.36 (16.1% above fair value)
Industry Position: 57% above the Medical Distribution median (#74 of 115)
No single metric tells the full story. See the SGX:1J5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include the Pharmaceutical and Medical Aesthetics segment; Proprietary Brands segment; and Digital Platform and E-Pharmacy segment. The Pharmaceutical and Medical Aesthetics segment engages in the business of marketing and selling a range of pharmaceutical and medical aesthetics products with exclusivity in the relevant ASEAN countries. The Proprietary Brands segment develops, markets, and sells dermatological, pharmaceuticals and health supplement products. The Digital Platform and E-Pharmacy segment is a digital platform servicing procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies, mainly in Singapore.
82GF Score
Get the complete analysis for SGX:1J5
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1J5 has been successfully added to your 
